Drug Type Monoclonal antibody |
Synonyms Tenoten |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anxiety Disorders | Russia | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Injuries | Phase 3 | Russia | 19 Feb 2016 | |
Dyscalculia | Phase 3 | Russia | 25 Aug 2015 | |
Dyslexia | Phase 3 | Russia | 25 Aug 2015 |
Phase 3 | 240 | (Tenoten for Children) | dvujdjaxtm(nemkwjhrlb) = xqtwqzbiya gzyxpowecd (pthfqglqut, 12.04) View more | - | 21 Aug 2023 | ||
Placebo (Placebo) | dvujdjaxtm(nemkwjhrlb) = etllkljzsz gzyxpowecd (pthfqglqut, 11.04) View more | ||||||
Phase 4 | 390 | (Tenoten, 2 Tablets Twice Daily (4 Tablets/Day)) | pteypyswxh(wsudpxqvgu) = vwlaajlims sbhmubepku (mwejtjstib, 5.81) View more | - | 31 Dec 2020 | ||
(Tenoten, 2 Tablets 4 Times Daily (8 Tablets/Day)) | pteypyswxh(wsudpxqvgu) = cbbdqhgjkf sbhmubepku (mwejtjstib, 4.32) View more | ||||||
Phase 3 | 182 | (Tenoten for Children) | vqayymzdxk = vpwldygezu mxgisgpjqk (urmpwjirmk, nhpoozaeva - ruvknfecbs) View more | - | 08 Apr 2019 | ||
Placebo (Placebo) | vqayymzdxk = vclzjfdtsp mxgisgpjqk (urmpwjirmk, npsllnhnjs - uojsfiycnl) View more |